SPG7 Gene NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Spastic Paraplegia
The SPG7 Gene NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, specifically designed to identify mutations in the SPG7 gene that cause hereditary spastic paraplegia type 7 (HSP7). This advanced genetic screening utilizes next-generation sequencing technology to provide comprehensive analysis of the SPG7 gene, enabling accurate diagnosis and personalized treatment planning for individuals experiencing progressive neurological symptoms.
What Does the SPG7 Gene Test Measure?
This sophisticated genetic test specifically targets and analyzes the SPG7 gene, which encodes the paraplegin protein essential for mitochondrial function in nerve cells. The test detects:
- Pathogenic variants and mutations in the SPG7 gene
- Single nucleotide polymorphisms (SNPs) associated with HSP7
- Copy number variations affecting gene function
- Novel genetic alterations impacting paraplegin production
- Inheritance patterns for family risk assessment
Who Should Consider SPG7 Genetic Testing?
This test is particularly recommended for individuals experiencing:
- Progressive leg stiffness and spasticity
- Difficulty walking or changes in gait pattern
- Muscle weakness in lower extremities
- Family history of hereditary spastic paraplegia
- Unexplained neurological symptoms beginning in adulthood
- Progressive balance and coordination issues
- Urinary urgency or bladder control problems
- Muscle cramps and fatigue with physical activity
Clinical Benefits of SPG7 Genetic Testing
Undergoing SPG7 genetic testing provides numerous clinical advantages:
- Accurate Diagnosis: Confirms or rules out hereditary spastic paraplegia type 7
- Early Intervention: Enables proactive management of symptoms
- Family Planning: Provides crucial information for genetic counseling
- Personalized Treatment: Guides targeted therapeutic approaches
- Prognostic Information: Helps predict disease progression
- Research Participation: Opens opportunities for clinical trials
Understanding Your Test Results
Your SPG7 genetic test results will fall into one of several categories:
- Positive Result: Identifies pathogenic mutations confirming HSP7 diagnosis
- Negative Result: No SPG7 mutations detected, suggesting alternative causes
- Variant of Uncertain Significance: Identifies genetic changes requiring further study
- Carrier Status: Identifies individuals who may pass mutations to offspring
All results include comprehensive interpretation by our board-certified genetic counselors and neurologists, ensuring you receive complete understanding of your genetic profile and its implications.
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We provide comprehensive SPG7 genetic testing services across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee.
Take Control of Your Neurological Health
Don’t let uncertainty about hereditary spastic paraplegia control your life. Our SPG7 Gene NGS Genetic DNA Test provides the clarity you need for informed healthcare decisions. With results available in 3-4 weeks and comprehensive genetic counseling included, you’ll receive the expert guidance necessary to understand your genetic profile and plan your healthcare journey.
Ready to take the next step? Book your SPG7 genetic test today by calling our genetic specialists at +1(267) 388-9828 or schedule your appointment online. Early detection leads to better management and improved quality of life.
